1. Expert explains how COVID-19 vaccine distribution will work  WCVB Channel 5 Boston
  2. J&J starts two-dose trial of its Covid-19 vaccine candidate  CNBC
  3. France to launch Covid-19 vaccine campaign in January  FRANCE 24 English
  4. How you may get your Covid-19 jab from a charity volunteer  Daily Mail
  5. Who will be the first to get COVID-19 vaccines?  Taiwan News
  6. View Full coverage on Google News

France said Tuesday it was preparing to kick off a nationwide Covid vaccination campaign in January when it hopes virus shots will be approved and available. France said Tuesday it was preparing to kick off a nationwide Covid vaccination campaign in January when it hopes virus shots will be approved and available. 

France to launch Covid-19 vaccine campaign in January

St John Ambulance is offering to teach those who are not first aiders how to administer injections. The charity usually provides first aid at more than 20,000 events each year.St John Ambulance is offering to teach those who are not first aiders how to administer injections. The charity usually provides first aid at more than 20,000 events each year.

How you may get your Covid-19 jab from a charity volunteer | Daily Mail Online

Sen. Rob Portman, R-Ohio, said Tuesday he's trying to put together a bipartisan proposal for a narrow coronavirus relief bill in the lame-duck session.Sen. Rob Portman, R-Ohio, said Tuesday he's trying to put together a bipartisan proposal for a narrow coronavirus relief bill in the lame-duck session.

Facebook

Portman will participate in a Phase 3 clinical trial for the coronavirus vaccine. He's the first senator to participate in a trial and hopes it will promote safety of vaccines once approved.Portman will participate in a Phase 3 clinical trial for the coronavirus vaccine. He's the first senator to participate in a trial and hopes it will promote safety of vaccines once approved.

Ohio Republican Senator Portman Announces Participation In Vaccine Trial : Coronavirus Updates : NPR

S&P 500 Futures bulls catch a breather around 3,620, down 0.10% intraday, amid the initial hour of Tokyo open. In doing so, the risk barometer steps bS&P 500 Futures bulls catch a breather around 3,620, down 0.10% intraday, amid the initial hour of Tokyo open. In doing so, the risk barometer steps b

S&P 500 Futures hold 3,600, print mild losses amid vaccine hopes, virus woes

Who will be the first to get COVID-19 vaccines? | 2020/11/17Who will be the first to get COVID-19 vaccines?

Who will be the first to get COVID-19 vaccines? | Taiwan News | 2020/11/17

Two top doctors lay out why they think people will take Moderna's vaccine, if it prevents them from catching COVID-19.Two top doctors lay out why they think people will take Moderna's vaccine, if it prevents them from catching COVID-19.

Moderna coronavirus vaccine side effects: Fatigue, aches, pain - Business Insider

The French government has said it is aiming to kick off a nationwide Covid-19 vaccination campaign in January, if the vaccine is approved by the European Medicines Agency.The French government has said it is aiming to kick off a nationwide Covid-19 vaccination campaign in January, if the vaccine is approved by the European Medicines Agency.

France targets January for Covid-19 vaccination campaign launch

Johnson & Johnson is confident that it has a one-dose knockout vaccine that can protect against COVID-19, but it’s now starting a late-stage two-dose test just in case.Johnson & Johnson is confident that it has a one-dose knockout vaccine that can protect against COVID-19, but it’s now starting a late-stage two-dose test just in case.

J&J, erring on caution, tests new 2-dose regimen for COVID-19 vaccine | FierceBiotech

LONDON: Johnson & Johnson launched a new large-scale late-stage trial on Monday to test a two-dose regimen of its experimental COVID-19 vaccine and evaluate potential incremental benefits for the duration of protection with a second dose. The US drugmaker plans to enrol up to 30,000 participants for the study and run it in parallel with a one-dose trial with as many as 60,000LONDON: Johnson & Johnson launched a new large-scale late-stage trial on Monday to test a two-dose regimen of its experimental COVID-19 vaccine and evaluate potential incremental benefits for the

J&J starts two-dose trial of its COVID-19 vaccine candidate | Arab News

A vaccine being developed at the Oxford University against COVID-19 could see an Indian roll-out in December, experts say.

India sees COVID-19 vaccine by end December

Johnson & Johnson (NYSE: JNJ) has started the two-dose Phase 3 trial of its experimental COVID-19 vaccine, dubbed "ENSEMBLE 2," the pharmaceutical company announced Sunday.What Happened: Johnson & Johnson aims to administer its experimental COVID-19 vaccine to 30,000 volunteers globally as part of the trial, through its subsidiary Janssen.The company said the two-dose late-stage trial will run in parallel to "ENSEMBLE," the single-dose regimen trial it had announced in September. Johnson & Johnson said it continues to enroll volunteers in the first study and is on track to meet its target of 60,000 participants worldwide.Reuters reported earlier in the day that the New Jersey-based pharmaceutical giant is enrolling 6,000 volunteers at 17 sites in the United Kingdom for the two-dose Phase 3 trial.Volunteers will be given the first dose of the experimental vaccine called Ad26COV2, or a placebo, followed by the second dose or the placebo 57 days later, as per the newswire. Ad26COV2 uses an adenovirus vector to transport the immunizing protein into the body. Why It Matters: The Phase 3 trial is the final step before drugmakers approach the regulators for approval.Positive results from the single-shot trial will simplify the distribution of millions of doses compared to leading rivals requiring two doses. The double-dose trial's efficacy will be affected if the participant fails to return to get the second shot.It is the third experimental COVID-19 vaccine to enter Phase 3 trials in the U.K., followed by Novavax, Inc (NASDAQ: NVAX), and AstraZeneca plc (NASDAQ: AZN). "All the vaccines that are being [trialed] work by generating immune responses to the same part of the coronavirus as the RNA vaccine that has announced some interim early results," Saul Faust, J&J's chief investigator said on the U.K. trial, as per the Financial Times. Faust also said that it is important to pursue trials of many different vaccines from many different manufacturers to ensure global supply.The two-dose trial will last for 12 months and complete the recruitment of participants by March 2021.Price Action: J&J shares closed 1.08% higher at $149.90 on Friday.See more from Benzinga * Click here for options trades from Benzinga * COVID-19 Vaccines To Generate over B Annual Revenue, Analyst Say * Johnson & Johnson Strikes COVID-19 Vaccine Manufacturing Deal With South Africa's Aspen(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Johnson & Johnson (NYSE: JNJ) has started the two-dose Phase 3 trial of its experimental COVID-19 vaccine, dubbed "ENSEMBLE 2," the pharmaceutical company announced Sunday.What Happened: Johnson & Johnson aims to administer its experimental COVID-19 vaccine to 30,000 volunteers globally as part of the trial, through its subsidiary Janssen.The company said the two-dose late-stage trial will run in parallel to "ENSEMBLE," the single-dose regimen trial it had announced in September. Johnson & Johnson said it continues to enroll volunteers in the first study and is on track to meet its target of 60,000 participants worldwide.Reuters reported earlier in the day that the New Jersey-based pharmaceutical giant is enrolling 6,000 volunteers at 17 sites in the United Kingdom for the two-dose Phase 3 trial.Volunteers will be given the first dose of the experimental vaccine called Ad26COV2, or a placebo, followed by the second dose or the placebo 57 days later, as per the newswire. Ad26COV2 uses an adenovirus vector to transport the immunizing protein into the body. Why It Matters: The Phase 3 trial is the final step before drugmakers approach the regulators for approval.Positive results from the single-shot trial will simplify the distribution of millions of doses compared to leading rivals requiring two doses. The double-dose trial's efficacy will be affected if the participant fails to return to get the second shot.It is the third experimental COVID-19 vaccine to enter Phase 3 trials in the U.K., followed by Novavax, Inc (NASDAQ: NVAX), and AstraZeneca plc (NASDAQ: AZN). "All the vaccines that are being [trialed] work by generating immune responses to the same part of the coronavirus as the RNA vaccine that has announced some interim early results," Saul Faust, J&J's chief investigator said on the U.K. trial, as per the Financial Times. Faust also said that it is important to pursue trials of many different vaccines from many different manufacturers to ensure global supply.The two-dose trial will last for 12 months and complete the recruitment of participants by March 2021.Price Action: J&J shares closed 1.08% higher at $149.90 on Friday.See more from Benzinga * Click here for options trades from Benzinga * COVID-19 Vaccines To Generate over B Annual Revenue, Analyst Say * Johnson & Johnson Strikes COVID-19 Vaccine Manufacturing Deal With South Africa's Aspen(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Johnson & Johnson Begins Two-Dose Phase 3 Trial Of COVID-19 Vaccine

The development and availability of a coronavirus vaccine could improve the outlook for the battered tourism industry but it is unlikely to convince consumers to spend more money in the short term.The development and availability of a coronavirus vaccine could improve the outlook for the battered tourism industry but it is unlikely to convince consumers to spend more money in the short term.

Most consumers unlikely to spend more because of vaccine — survey | Inquirer News

Johnson & Johnson has launched a second global Phase 3 trial for its Janssen COVID-19 vaccine candidate: this time exploring a 2-dose regimen (its existing Phase 3 trial is for a 1-dose regimen). Johnson & Johnson has launched a second global Phase 3 trial for its Janssen COVID-19 vaccine candidate: this time exploring a 2-dose regimen (its existing Phase 3 trial is for a 1-dose regimen).

J&J launches Phase 3 trial for 2-dose COVID-19 vaccine

Biological E. Ltd has started human trials of its COVID-19 vaccine candidate and expects results by February, the drugmaker said on Monday.Biological E. Ltd has started human trials of its COVID-19 vaccine candidate and expects results by February, the drugmaker said on Monday.

Hyderabad-Based Firm Biological E Starts Human Trials Of COVID-19 Vaccine Candidate

Health burden extremely high in France, more patients in hospital than in first virus wave, says health minister - Anadolu AgencyHealth burden extremely high in France, more patients in hospital than in first virus wave, says health minister - Anadolu Agency

France hopes for January start on COVID-19 vaccinations

Paris, France, Nov 17 - France said Tuesday it was preparing to kick off a nationwide Covid vaccination campaign in January when it hopes virus shots will - Kenya breaking news | Kenya news today | Capitalfm.co.keParis, France, Nov 17 – France said Tuesday it was preparing to kick off a nationwide Covid vaccination campaign in January when it hopes virus shots will be approved and available. The government is worried that millions of French people will refuse coronavirus shots, even after a vaccine was found to be nearly 95 percent effective […]

France aiming to start Covid vaccinations in January » Capital News

Scientists have also found that mouthwash can eradicate the virus in 30 secondsScientists have also found that mouthwash can eradicate the virus in 30 seconds

Coronavirus morning headlines as army of volunteers with no medical background are set to be recruited to deliver Covid-19 vaccine - Wales Online

Progress toward creating vaccines against COVID-19 has accelerated this month, with good results from other vaccine makers.Progress toward creating vaccines against COVID-19 is accelerating.

Sucuri WebSite Firewall - Access Denied

According to Stop & Shop, its pharmacies will be among the first to administer the vaccine once it’s approved.

Stop & Shop signs on to administer future COVID-19 vaccines

Allen Fire Chief Jonathan Boyd volunteered to be part of drugmaker Moderna's COVID-19 vaccine trial. It may be almost 95% effective against the virus.Allen Fire Chief Jonathan Boyd volunteered to be part of drugmaker Moderna's COVID-19 vaccine trial. It may be almost 95% effective against the virus.

Politicians around the world face ‘huge task’ in building up trust for roll-out, says pollsterPoliticians around the world face ‘huge task’ in building up trust for roll-out, says pollster

Distrust of government leading to ‘alarming’ vaccine scepticism, poll finds | The Independent

An experimental coronavirus vaccine developed by West China Hospital has entered a mid-stage human test, authorities of China's southwestern province of Sichuan said on Tuesday.An experimental coronavirus vaccine developed by West China Hospital has entered a mid-stage human test, authorities of China's southwestern province of Sichuan said on Tuesday.

West China Hospital's Covid-19 vaccine candidate enters mid-stage human trial

There’s nothing we can do about Portman until he runs for reelection. Between now and then, it is essential that we find an intelligent, rational, electable opponent who will be responsive to the people of Ohio, rather than the senator from Kentucky or Donald Trump, writes Sheldon M. Gisser of Pepper Pike in a letter to the editor.

Start now to identify candidate who can take on Sen. Portman in 2022 - cleveland.com

Thousands of other volunteers could be used in patient-facing roles, such as patient advocates and first aiders. Thousands of other volunteers could be used in patient-facing roles, such as patient advocates and first aiders.

COVID-19: St John Ambulance to train thousands of volunteers to administer coronavirus jab | UK News | Sky News

Johnson & Johnson has launched a late-stage trial for its second COVID-19 vaccine, a report said Monday.Johnson & Johnson has launched a late-stage trial for its second COVID-19 vaccine, a report said Monday. The New Jersey-based drugmaker had already been conducting a stage-three trial for a

Johnson & Johnson launches late-stage trial for COVID-19 vaccine

With an emergency use authorization of a COVID-19 vaccine potentially coming soon, plans are being made on where and how the vaccine will be distributed.With an emergency use authorization of a COVID-19 vaccine potentially coming soon, plans are being made on where and how the vaccine will be distributed.

Stop & Shop among supermarket, pharmacy chains planning to offer COVID-19 vaccine | WPRI.com

Quincy-based Stop & Shop has signed on to be among the first pharmacies in the country to administer future coronavirus vaccines.Quincy-based Stop & Shop has signed on to be among the first pharmacies in the country to administer future coronavirus vaccines.

Stop & Shop Among Supermarket Chains Planning To Offer Coronavirus Vaccines In Pharmacies – CBS Boston

Moderna’s results, alongside Pfizer’s, are a major validation of a new way of creating vaccines — and possibly other types of drugs — that has been ye...Moderna’s results, alongside Pfizer’s, are a major validation of a new way of creating vaccines — and possibly other types of drugs — that has been ye...

Britain will be the first country to run final stage trials of an experimental coronavirus vaccine being developed by pharmaceutical company Janssen, which is a subsidiary of Johnson & JohnsonBritain will be the first country to run final stage trials of an experimental coronavirus vaccine being developed by pharmaceutical company Janssen, which is a subsidiary of Johnson & Johnson

UK to run final stage trials of Janssen Covid vaccine - The Washington Post

The Ohio Republican is the first lawmaker to disclose participation in clinical trials for a coronavirus shot.

Portman reveals he's enrolled in Covid-19 vaccine trial - POLITICO

The Montreal Gazette spoke with Dr. Caroline Quach, a pediatric microbiologist and infectologist.

Will Canada be getting a COVID-19 vaccine soon? | Montreal Gazette

Will Canada be getting a COVID-19 vaccine soon? | Montreal Gazette

AFP's correspondent in Miami, Leila Macor, took part in such a trial organised by US biotech firm Moderna, which announced Monday that its experimental vaccine was nearly 95% effective.AFP's correspondent in Miami, Leila Macor, took part in such a trial organised by US biotech firm Moderna, which announced Monday that its experimental vaccine was nearly 95% effective.

What is it like to take part in a vaccine trial?

A U.S. senator is participating in a COVID-19 vaccine study, hoping to encourage others to volunteer to take part in testing.(watch our story above for more on the COVID-19 vaccine distribution plan amid Moderna, Pfizer vaccine news) CINCINNATI (AP)— A U.S. senator is participating in a COVID-19 vaccine study,…

Ohio senator joins COVID-19 vaccine study to set example

Moderna CEO Stephane Bancel on Monday discussed some of the biotech giant's coronavirus vaccine side effects among trial participants, amid positive news of 94.5% efficacy, per an interim analysis.Moderna CEO Stephane Bancel on Monday discussed some of the biotech giant's coronavirus vaccine side effects among trial participants, amid positive news of 94.5% efficacy, per an interim analysis.

Biological E. Limited, Dynavax Technologies Corporation and Baylor College of Medicine announced that BE has initiated a Phase I/II clinical trial of its...Biological E. Limited, Dynavax Technologies Corporation and Baylor College of Medicine announced that BE has initiated a Phase I/II clinical trial of its...

Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India | BCM

When the vaccine is available, more than 250 Stop & Shop pharmacies in the Northeast will offer it.

Stop & Shop will offer COVID vaccine when available at no cost to customers in its pharmacies across Northeast - masslive.com

Biopharmaceuticals player Biological E Limited (BE), which is working on a Covid-19 vaccine candidate along with US-based biopharma company Dynavax TeBiopharmaceuticals player Biological E Limited (BE), which is working on a Covid-19 vaccine candidate along with US-based biopharma company Dynavax Te

Biological E, BCM Covid-19 vaccine candidate begins Phase I/II human trials | Hyderabad News - Times of India

The Jannsen vaccine is among the six experimental coronavirus vaccines that Britain has ordered as part of a planned 350 million-dose stockpile.The Jannsen vaccine is among the six experimental coronavirus vaccines that Britain has ordered as part of a planned 350 million-dose stockpile.

Janssen to begin final stage trials of coronavirus candidate in the U.K. - National | Globalnews.ca

Thousands of volunteers with no medical background could be trained up to administer the coronavirus vaccine in a bid to deliver on the Government's mass immunisation plans.Thousands of volunteers with no medical background could be trained up to administer the coronavirus vaccine in a bid to deliver on the Government's mass immunisation plans.

Thousands of volunteers with no medical background could be trained to deliver coronavirus vaccine | Evening Standard

Britain will be the first country to run final stage trials of an experimental coronavirus vaccine being developed by the pharmaceutical company Janssen, a subsidiary of Johnson & Johnson.Britain will be the first country to run final stage trials of an experimental coronavirus vaccine being developed by the pharmaceutical company Janssen, a subsidiary of Johnson & Johnson.

U.K. to run final stage trials of Janssen COVID-19 vaccine | CTV News

Stop & Shop announced on Monday that it would be among the first pharmacies in the country to give out the future COVID-19 vaccines.Stop & Shop announced on Monday that it would be among the first pharmacies in the country to give out the future COVID-19 vaccines.

Stop & Shop to be among the first pharmacies to administer future COVID vaccine | News | wfsb.com

Human trials began in India Monday on an inexpensive coronavirus vaccine developed by Baylor College of Medicine scientists, a candidate expected to be widely deployed in the Third World if it proves effective. <p>Human trials began in India Monday on an inexpensive coronavirus vaccine developed by Baylor College of Medicine scientists, a candidate expected to be widely deployed in the Third World if it proves effective.</p>

Baylor team’s vaccine starts human trials in India - HoustonChronicle.com

CHICOPEE, Mass. (WWLP) – Stop & Shops in Massachusetts has signed up to administer COVID-19 vaccines, once they are approved for use in the U.S. According to a news release sent to 22News from Stop & Shop, the partnership with the U.S. Department of Health & Human Services is designed to help provide access to […]CHICOPEE, Mass. (WWLP) – Stop & Shops in Massachusetts has signed up to administer COVID-19 vaccines, once they are approved for use in the U.S. According to a news release sent to 22News…

Stop & Shop pharmacies to provide COVID-19 vaccine at no cost | WWLP